These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 19064724)
1. Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo. Bruno B; Rotta M; Patriarca F; Mattei D; Allione B; Carnevale-Schianca F; Sorasio R; Rambaldi A; Casini M; Parma M; Bavaro P; Onida F; Busca A; Castagna L; Benedetti E; Iori AP; Giaccone L; Palumbo A; Corradini P; Fanin R; Maloney D; Storb R; Baldi I; Ricardi U; Boccadoro M Blood; 2009 Apr; 113(14):3375-82. PubMed ID: 19064724 [TBL] [Abstract][Full Text] [Related]
2. A comparison of allografting with autografting for newly diagnosed myeloma. Bruno B; Rotta M; Patriarca F; Mordini N; Allione B; Carnevale-Schianca F; Giaccone L; Sorasio R; Omedè P; Baldi I; Bringhen S; Massaia M; Aglietta M; Levis A; Gallamini A; Fanin R; Palumbo A; Storb R; Ciccone G; Boccadoro M N Engl J Med; 2007 Mar; 356(11):1110-20. PubMed ID: 17360989 [TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma. Giaccone L; Storer B; Patriarca F; Rotta M; Sorasio R; Allione B; Carnevale-Schianca F; Festuccia M; Brunello L; Omedè P; Bringhen S; Aglietta M; Levis A; Mordini N; Gallamini A; Fanin R; Massaia M; Palumbo A; Ciccone G; Storb R; Gooley TA; Boccadoro M; Bruno B Blood; 2011 Jun; 117(24):6721-7. PubMed ID: 21490341 [TBL] [Abstract][Full Text] [Related]
4. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo. Majolino I; Vignetti M; Meloni G; Vegna ML; Scimè R; Tringali S; Amaddii G; Coser P; Tribalto M; Raimondi R; Bergonzi C; Sajeva MR; Sica S; Ferrando F; Messina G; Mandelli F Haematologica; 1999 Sep; 84(9):844-52. PubMed ID: 10477460 [TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting. Rotta M; Storer BE; Sahebi F; Shizuru JA; Bruno B; Lange T; Agura ED; McSweeney PA; Pulsipher MA; Hari P; Maziarz RT; Chauncey TR; Appelbaum FR; Sorror ML; Bensinger W; Sandmaier BM; Storb RF; Maloney DG Blood; 2009 Apr; 113(14):3383-91. PubMed ID: 19015394 [TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic cell transplantation from unrelated donors in multiple myeloma: study from the Italian Bone Marrow Donor Registry. Passera R; Pollichieni S; Brunello L; Patriarca F; Bonifazi F; Montefusco V; Falda M; Montanari M; Guidi S; Giaccone L; Mordini N; Carella AM; Bavaro P; Milone G; Benedetti F; Ciceri F; Scimè R; Benedetti E; Castagna L; Festuccia M; Rambaldi A; Bacigalupo A; Corradini P; Bosi A; Boccadoro M; Bandini G; Fanin R; Bruno B Biol Blood Marrow Transplant; 2013 Jun; 19(6):940-8. PubMed ID: 23538113 [TBL] [Abstract][Full Text] [Related]
7. Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma. Maloney DG; Molina AJ; Sahebi F; Stockerl-Goldstein KE; Sandmaier BM; Bensinger W; Storer B; Hegenbart U; Somlo G; Chauncey T; Bruno B; Appelbaum FR; Blume KG; Forman SJ; McSweeney P; Storb R Blood; 2003 Nov; 102(9):3447-54. PubMed ID: 12855572 [TBL] [Abstract][Full Text] [Related]
8. Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality. Kröger N; Sayer HG; Schwerdtfeger R; Kiehl M; Nagler A; Renges H; Zabelina T; Fehse B; Ayuk F; Wittkowsky G; Schmitz N; Zander AR Blood; 2002 Dec; 100(12):3919-24. PubMed ID: 12393448 [TBL] [Abstract][Full Text] [Related]
9. Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma. Maffini E; Storer BE; Sandmaier BM; Bruno B; Sahebi F; Shizuru JA; Chauncey TR; Hari P; Lange T; Pulsipher MA; McSweeney PA; Holmberg L; Becker PS; Green DJ; Mielcarek M; Maloney DG; Storb R Haematologica; 2019 Feb; 104(2):380-391. PubMed ID: 30262560 [TBL] [Abstract][Full Text] [Related]
10. A Phase II trial of autologous stem cell transplantation followed by mini-allogeneic stem cell transplantation for the treatment of multiple myeloma: an analysis of Eastern Cooperative Oncology Group ECOG E4A98 and E1A97. Vesole DH; Zhang L; Flomenberg N; Greipp PR; Lazarus HM; Huff CA; Biol Blood Marrow Transplant; 2009 Jan; 15(1):83-91. PubMed ID: 19135946 [TBL] [Abstract][Full Text] [Related]